|Mr. John Stewart Sharman B Ec, BECON, C.A., CA, M.App.Fin||Chief Executive Officer||532.42k||N/A||1966|
|Mr. Salesh Balak B.A., BA, C.A., CA||CFO & Company Secretary||303.9k||N/A||1969|
|Mr. Nicholas Bliesner||Head of Operations||N/A||N/A||N/A|
|Mr. Steven Burgess||Head of Sales & Marketing||N/A||N/A||N/A|
|Mr. Luke Cossins B.Sc., M.B.A.||Head of Research & Development||N/A||N/A||N/A|
|Ms. Ann Chew B.Com., CPA, CIA||Head of People Strategy & Culture||N/A||N/A||N/A|
Universal Biosensors, Inc., through its subsidiaries, designs and develops electrochemical cells (strips) used in conjunction with point-of-use devices used in healthcare (point-of-care), wine, food, and agriculture industries in Australia, the Americas, Europe, and internationally. The company manufactures and distributes Prothrombin Time International Normalized Ratio coagulation test strips and Xprecia Stride and Xprecia Prime medical devices to monitor the effect of the anticoagulant therapy warfarin; and Sentia wine testing products, such as free SO2, malic acid, glucose, and fructose. It also offers non-diagnostic laboratory services and performs coagulation testing services. The company has a license agreement with LifeScan Global Corporation to develop a test strip and a meter to be used for the detection and monitoring of diabetes in non-humans. Universal Biosensors, Inc. was incorporated in 2001 and is based in Rowville, Australia.
Universal Biosensors, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.